Humana Inc. (ETR:HUM)
Germany · Delayed Price · Currency is EUR | Market Cap | 43.09B +48.3% |
| Revenue (ttm) | 127.51B +18.3% |
| Net Income | 1.12B -18.8% |
| EPS | 9.27 -18.8% |
| Shares Out | n/a |
| PE Ratio | 38.49 |
| Forward PE | 30.49 |
| Dividend | 3.06 (0.85%) |
| Ex-Dividend Date | Oct 30, 2026 |
| Volume | 23 |
| Open | 362.00 |
| Previous Close | 356.00 |
| Day's Range | 358.00 - 368.00 |
| 52-Week Range | 298.00 - 368.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |
About Humana
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and... [Read more]
Financial Performance
In 2025, Humana's revenue was $129.66 billion, an increase of 10.11% compared to the previous year's $117.76 billion. Earnings were $1.19 billion, a decrease of -1.57%.
Financial numbers in USD Financial StatementsNews
Humana Faces Medicare ‘Stars' Rating. The Result Will Test the Stock.
Improving Medicare Advantage ratings isn't easy. Stars are based on 40-some criteria that encompass patient experience surveys and a range of care metrics.
Cantor upgrades Humana into this week’s stars announcement
Cantor Fitzgerald upgraded Humana (HUM) to Overweight from Neutral with a price target of $460, up from $300. The firm cites higher confidence in Humana’s Medicare margin and stars recovery…
Humana upgraded to Overweight from Neutral at Cantor Fitzgerald
Cantor Fitzgerald analyst Sarah James upgraded Humana (HUM) to Overweight from Neutral with a $460 price target
BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients
SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence ...
Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) and the University of Louisville today announced the publication of a new economic impact report examining Humana's contributions across the s...
Humana announces 2027 Medicare Advantage plan offerings
As Medicare’s Annual Election Period begins Oct. 15, Humana (HUM) is offering 2027 Medicare Advantage plans designed to deliver high-value coverage with affordable monthly premiums. Members will have ...
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
Barclays upgrades Humana on confidence in star ratings boost
Barclays analyst Andrew Mok upgraded Humana (HUM) to Overweight from Equal Weight with a price target of $515, up from $407. The firm cites greater conviction in Humana’s Medicare star…
Humana upgraded to Overweight from Equal Weight at Barclays
Barclays upgraded Humana (HUM) to Overweight from Equal Weight with a $515 price target
New Humana research finds association between pharmacy care coordination services and improved health outcomes for cancer patients
LOUISVILLE, Ky.--(BUSINESS WIRE)--A new research study finds an association between pharmacy care coordination services and improved health outcomes for cancer patients.
Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company's annual nationwide day of service. In its third year, Humana Community ...
Humana price target raised to $510 from $500 at BofA
BofA analyst Kevin Fischbeck raised the firm’s price target on Humana (HUM) to $510 from $500 and keeps a Buy rating on the shares. The firm is “ticking up” targets…
Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition.
Humana Board Declares Payment of Quarterly Dividend to Stockholders
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on November 27, 2026 to s...
Humana Foundation Names 2026 Scholarship Recipients
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), today announced 80 winners of college scholarships awarded through the Humana Foundation Scho...
DaVita enters care pact with Humana for chronic kidney disease patients
DaVita (DVA) announced a new value-based care agreement to deliver coordinated care to Humana (HUM) Medicare Advantage members with chronic kidney disease stages 3B-5. The company said, “Launched July...
As Health Insurers Gain Handle On Costs, Stocks Are Soaring Again
Following a parade of health insurance company earnings reports this summer, stocks are rising and costs appear to be under control for now.
Humana names Shantanu Nundy as Chief Medical Officer
Humana (HUM) announced that Shantanu Nundy, M.D., will join the company as Chief Medical Officer, effective August 31. Dr. Nundy will report to Jim Rechtin, Humana President and CEO, and…
Humana Names Dr. Shantanu Nundy as Chief Medical Officer
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that Shantanu Nundy, M.D., will join the company as Chief Medical Officer, effective August 31. A practicing physician, health...
Humana agrees not to reference Teva's Israel ties at US drug trial
Health insurer Humana has agreed not to refer to drugmaker Teva as an Israeli company at an upcoming U.S. drug price-fixing trial, after the drugmaker said public views on the Gaza war could unfairly...
Health insurers are dumping Medicare Advantage plans. Here's how many seniors could be affected.
Older adults could be scrambling for new health coverage next year, especially in rural markets that have fewer insurance choices.
Humana Healthy Horizons in Indiana collaborates with HealthStream
Humana (HUM) Healthy Horizons in Indiana, Humana’s Medicaid managed care plan, is collaborating with HealthStream (HSTM). “Expanding access to training is one of the most direct ways we can grow…
Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce
INDIANAPOLIS--(BUSINESS WIRE)--Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce.
James P. Holland to Join Humana as Medicaid President
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that James “J.P.” Holland will join the company as senior vice president and President of Medicaid, effective August 17. In th...
Humana price target raised to $393 from $316 at JPMorgan
JPMorgan analyst Lisa Gill raised the firm’s price target on Humana (HUM) to $393 from $316 and keeps a Neutral rating on the shares.